The Optimal Therapy for Tinea Capitis
2000; Wiley; Volume: 17; Issue: 4 Linguagem: Inglês
10.1046/j.1525-1470.2000.01789.x
ISSN1525-1470
Autores Tópico(s)Plant Pathogens and Fungal Diseases
ResumoPediatric DermatologyVolume 17, Issue 4 p. 325-326 The Optimal Therapy for Tinea Capitis Sheila Fallon Friedlander M.D., Sheila Fallon Friedlander M.D. Division of Pediatric Dermatology, Children's Hospital and Medical Center, San Diego, CaliforniaSearch for more papers by this author Sheila Fallon Friedlander M.D., Sheila Fallon Friedlander M.D. Division of Pediatric Dermatology, Children's Hospital and Medical Center, San Diego, CaliforniaSearch for more papers by this author First published: 25 December 2001 https://doi.org/10.1046/j.1525-1470.2000.01789.xCitations: 14 Address correspondence to Sheila Fallon Friedlander, M.D., Division of Pediatric Dermatology #5092, Children's Hospital & Medical Center, 3030 Children's Way, San Diego, California 92123-4228. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. REFERENCES 1 Gentles JC. Experimental ringworm in guinea pigs: oral treatment with griseofulvin. Nature 1958; 182: 476 477. 2 Lobato MN, Vugia DJ, Frieden IJ. Tinea capitis in California children: a population-based study of a growing epidemic. Pediatrics 1997; 99: 551 554. 3 Friedlander SF. The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis. Pediatr Infect Dis 1999; 18: 205 210. 4 Bennett ML, Fleischer Ab Jr, Loveless JW, Feldman SR. Oral griseofulvin remains the treatment of choice for tinea capitis in children. Pediatr Dermatol 2000; 17: 304 310. 5 Tanz RR, Hebert AA, Esterly NB. Treating tinea capitis: Should ketoconazole replace griseofulvin? J Pediatr 1988; 112: 987 991. 6 Williams JV, Honig PJ, McGinley KJ, Leyden JJ. Semi-quantitative study of tinea capitis and the asymptomatic carrier state in inner-city school children. Pediatrics 1995; 96: 265 267. 7 Abdel-Rahman SM, Nahata MC, Powell SA. Response to initial griseofulvin therapy in pediatric patients with tinea capitis. Ann Pharmacother 1997; 31: 406 410. 8 Caceres-Rios H, Rueda M, Ballona R, Bustamante B. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. J Am Acad Dermatol 2000; 42: 80 84. 9 O'sullivan DP, Needham CA, Bangs A, et al. Postmarketing surveillance of oral terbinafine in the UK: report of a large cohort study. Br J Clin Pharmacol 1996; 42: 559 565. Citing Literature Volume17, Issue4July/August 2000Pages 325-326 ReferencesRelatedInformation
Referência(s)